Sun Life Financial: These Are The 6 Biggest Factors Powering Our Optimism! 

Sun Life Financial’s Q4 2024 results exhibit a balanced performance marked by strengths and some headwinds. The quarter was characterized by growth in multiple segments, while specific challenges were evident primarily in the U.S. operations, particularly within the U.S. Health and Risk Solutions sector. The company reported underlying net income of $965 million, slightly down by 2% compared to the prior year. This decline was largely due to adverse morbidity experience in the U.S., with the stop-loss segment experiencing higher claims severity, a phenomenon noted across the industry. Despite these challenges, the U.S. segment showed promising dynamics in other areas, such as the Group Benefits, which grew 6% year-over year due to successful strategic executions. However, the U.S. Dental business faced disruptions from fewer government contracts available in the market.